[The treatment of cardiac arrhythmias: complexity and schematization].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000628:therapy; D001281:Atrial Fibrillation / Q000628:therapy; D001282:Atrial Flutter / Q000628:therapy; D001572:Benzofurans / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000506:poisoning / Q000627:therapeutic use*; D004554:Electric Countershock; D008012:Lidocaine / Q000494:pharmacology; D010672:Phenytoin / Q000627:therapeutic use; D011188:Potassium / Q000494:pharmacology; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use*; D013610:Tachycardia / Q000628:therapy; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001572:Benzofurans; D004071:Digitalis Glycosides; D010672:Phenytoin; D008012:Lidocaine; D014700:Verapamil; D011802:Quinidine; D011342:Procainamide; D011188:Potassium
Traitement des arythmies cardiaques: complexité et schématisation.